Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Differentially-Methylated Genes and Pathways in Patients with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage. | J Korean Neurosurg Soc | 2022 | 34320780 | PubTator, text mining | PubMed |
| Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease. | Alzheimers Dement | 2022 | 34223696 | PubTator, text mining | PubMed |
| Resident Macrophages and Their Potential in Cardiac Tissue Engineering. | Tissue Eng Part B Rev | 2022 | 34088222 | PubTator, text mining | PubMed |
| Spinal A3 adenosine receptor activation acutely restores morphine antinociception in opioid tolerant male rats. | J Neurosci Res | 2022 | 34075613 | PubTator, text mining | PubMed |
| Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84. | Br J Pharmacol | 2022 | 32869860 | PubTator, text mining | PubMed |
| Group Sparse Joint Non-Negative Matrix Factorization on Orthogonal Subspace for Multi-Modal Imaging Genetics Data Analysis. | IEEE/ACM Trans Comput Biol Bioinform | 2022 | 32750856 | PubTator, text mining | PubMed |
| Adenosine A2A receptor antagonists: from caffeine to selective non-xanthines. | Br J Pharmacol | 2022 | 32424811 | PubTator, text mining | PubMed |
| Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developments. | Osteoarthr Cartil Open | 2021 | 36474768 | PubTator, text mining | PubMed |
| Bilateral squamosal synostosis: unusual presentation of chromosome 1p12-1p13.3 deletion. Illustrative case. | J Neurosurg Case Lessons | 2021 | 36034505 | PubTator, text mining | PubMed |
| Convergent synthesis of 2-thioether-substituted (N)-methanocarba-adenosines as purine receptor agonists. | RSC Adv | 2021 | 35480676 | PubTator, text mining | PubMed |
| Potential therapeutic targets and molecular details of anthocyan-treated inflammatory bowel disease: a systematic bioinformatics analysis of network pharmacology. | RSC Adv | 2021 | 35423341 | PubTator, text mining | PubMed |
| Bone-on-a-chip: microfluidic technologies and microphysiologic models of bone tissue. | Adv Funct Mater | 2021 | 35422682 | PubTator, text mining | PubMed |
| Purinergic Receptors in the Airways: Potential Therapeutic Targets for Asthma? | Front Allergy | 2021 | 35386996 | PubTator, text mining | PubMed |
| Caffeine Therapy for Apnea of Prematurity: Role of the Circadian CLOCK Gene Polymorphism. | Front Pharmacol | 2021 | 35145399 | PubTator, text mining | PubMed |
| Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies. | Front Pharmacol | 2021 | 35140610 | PubTator, text mining | PubMed |
| A2 adenosine receptor contributes to the development of cow's milk protein allergy via regulating regulatory T cells. | Iran J Basic Med Sci | 2021 | 35096296 | PubTator, text mining | PubMed |
| Tianma Formula Alleviates Dementia via ACER2-Mediated Sphingolipid Signaling Pathway Involving Aβ. | Evid Based Complement Alternat Med | 2021 | 35069753 | PubTator, text mining | PubMed |
| Toward Overcoming Treatment Failure in Rheumatoid Arthritis. | Front Immunol | 2021 | 35003068 | PubTator, text mining | PubMed |
| Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance. | Int J Mol Sci | 2021 | 34948316 | PubTator, text mining | PubMed |
| Exploration of genes and tumor infiltrating lymphocytes in female lung adenocarcinoma microenvironment that predicted prognosis. | Medicine (Baltimore) | 2021 | 34941080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=20